2016
DOI: 10.1016/j.jcis.2015.09.068
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric nanostructures with pH-labile core for controlled drug release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…The reduction-sensitive nanoassemblies are susceptible to cleavage under a reductive environment involving thiol–disulfide exchange reactions as compared with their reduction-insensitive counterparts. , Additionally, non-cross-linked polymeric micellar nanostructures have a major disadvantage owing to their tendency to disassemble on dilution below a certain concentration, resulting in instability and uncontrolled drug release when injected into the body. , Therefore, design and implementation of versatile strategies where the micellar cores can undergo cross-linking without the involvement of any external cross-linker should enable selective tailoring of the nanomaterials for a number of applications in various fields related to delivery of drugs and other biomolecules.…”
Section: Introductionmentioning
confidence: 99%
“…The reduction-sensitive nanoassemblies are susceptible to cleavage under a reductive environment involving thiol–disulfide exchange reactions as compared with their reduction-insensitive counterparts. , Additionally, non-cross-linked polymeric micellar nanostructures have a major disadvantage owing to their tendency to disassemble on dilution below a certain concentration, resulting in instability and uncontrolled drug release when injected into the body. , Therefore, design and implementation of versatile strategies where the micellar cores can undergo cross-linking without the involvement of any external cross-linker should enable selective tailoring of the nanomaterials for a number of applications in various fields related to delivery of drugs and other biomolecules.…”
Section: Introductionmentioning
confidence: 99%
“…To enhance efficiency of existing medication and to develop new therapeutic options for currently untreatable medical conditions, pharmaceutical research focuses not only on the screening of new active pharmaceutical ingredients (APIs) but also on the exploration of different administration routes and alternative dosage forms. Polymers can assume various crucial functions in drug formulations, providing protection against premature release 1 , 2 , stabilizing specific solid state forms 3 , 4 , enabling site-specific drug activity 5 , 6 or being functionalized themselves by anchoring drugs or proteins directly to their structure ( polymer therapeutics ) 7 . The drug release from such polymer systems is usually facilitated by either degradation/erosion of the polymer host or by diffusion of the drug; for the latter mechanism, matrix-, reservoir- and hydrogel-based systems are usually differentiated 8 .…”
Section: Introductionmentioning
confidence: 99%
“…As can be seen in Figure 4i, it occurs by attaching various agents as side groups to the polymer chain and breaking the bonds at the appropriate pH value [57][58][59][60]. In addition, as shown in Figure 4j, the destruction of the polymeric network structure or the destruction of the cross-linked micelle structure can be achieved by breaking down the groups designed as cross-linkers in a pH-responsive manner [61][62][63][64][65].…”
Section: Ph-responsive Polymersmentioning
confidence: 99%